To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis
- Status
- RECRUITING
- Phase
- N/A
Effects of Anesthetic Methods on Hepatic Cancer Cell Function in Vitro
- Status
- COMPLETED
- Phase
- NA
A Multicenter Cancer Biospecimen Collection Study
- Status
- RECRUITING
- Phase
- N/A
GPC3-CAR-T Cells for the Hepatocellular Carcinoma
- Status
- SUSPENDED
- Phase
- PHASE1
Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)
- Status
- TERMINATED
- Phase
- PHASE1
Role of CEUS as a Secondary Diagnostic Modality
- Status
- UNKNOWN
- Phase
- NA
TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Optimization for Regorafenib in HCC
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Prediction of Liver-related Outcomes After HCV Cure
- Status
- UNKNOWN
- Phase
- N/A
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
- Status
- COMPLETED
- Phase
- N/A
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation
- Status
- RECRUITING
- Phase
- NA
A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function
- Status
- UNKNOWN
- Phase
- PHASE2